CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.110
+0.010 (0.48%)
At close: Apr 2, 2025, 4:00 PM
2.207
+0.097 (4.60%)
After-hours: Apr 2, 2025, 7:59 PM EDT
CASI Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 13.47 | 17.08 | 47.11 | 38.7 | 57.06 | Upgrade
|
| Short-Term Investments | 2.62 | 13.69 | 4.23 | 9.87 | 9.31 | Upgrade
|
| Cash & Short-Term Investments | 16.09 | 30.77 | 51.34 | 48.57 | 66.37 | Upgrade
|
| Cash Growth | -47.70% | -40.06% | 5.69% | -26.82% | 22.36% | Upgrade
|
| Accounts Receivable | 15.35 | 9.55 | 12.97 | 9.8 | 4.65 | Upgrade
|
| Other Receivables | - | 0.59 | - | - | - | Upgrade
|
| Receivables | 15.35 | 10.14 | 12.97 | 9.8 | 4.65 | Upgrade
|
| Inventory | 5.25 | 15.88 | 6.14 | 1.91 | 1.36 | Upgrade
|
| Prepaid Expenses | 2.89 | 2.56 | 2.98 | 1.69 | 1.65 | Upgrade
|
| Total Current Assets | 39.58 | 59.34 | 73.42 | 61.97 | 74.03 | Upgrade
|
| Property, Plant & Equipment | 11.36 | 11.63 | 13.23 | 21.82 | 10.76 | Upgrade
|
| Long-Term Investments | 1.91 | 1.69 | 7.46 | 40.13 | 29.44 | Upgrade
|
| Other Intangible Assets | 0.24 | 1.84 | 1.06 | 12.2 | 13.21 | Upgrade
|
| Other Long-Term Assets | 0.59 | 0.77 | 1.06 | 2.18 | 0.3 | Upgrade
|
| Total Assets | 53.67 | 75.27 | 96.23 | 138.3 | 127.73 | Upgrade
|
| Accounts Payable | 2.72 | 4.44 | 3.29 | 2.22 | 3.26 | Upgrade
|
| Accrued Expenses | 15.34 | 7.63 | 7.64 | 6.04 | 1.97 | Upgrade
|
| Short-Term Debt | - | - | - | - | 1.29 | Upgrade
|
| Current Portion of Leases | - | 0.73 | 0.87 | 1.06 | 0.94 | Upgrade
|
| Current Income Taxes Payable | 18.39 | - | 1.9 | - | - | Upgrade
|
| Current Unearned Revenue | - | 2.54 | 2.62 | 0.06 | - | Upgrade
|
| Other Current Liabilities | - | 1.39 | 0.69 | 3.81 | 0.52 | Upgrade
|
| Total Current Liabilities | 36.45 | 16.73 | 17.01 | 13.19 | 7.98 | Upgrade
|
| Long-Term Debt | - | 18.9 | - | - | - | Upgrade
|
| Long-Term Leases | - | 1.62 | 0.48 | 1.11 | 0.97 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 2.83 | 2.35 | Upgrade
|
| Other Long-Term Liabilities | 15.37 | 13.87 | 11.82 | 13.22 | 12.87 | Upgrade
|
| Total Liabilities | 51.82 | 51.1 | 29.3 | 30.34 | 24.16 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 1.24 | Upgrade
|
| Additional Paid-In Capital | 713.3 | 695.79 | 691.77 | 696.22 | 658.25 | Upgrade
|
| Retained Earnings | -700.08 | -660.82 | -637.16 | -605.64 | -570.5 | Upgrade
|
| Treasury Stock | -9.6 | -9.6 | -9.33 | -8.03 | -8.03 | Upgrade
|
| Comprehensive Income & Other | -1.77 | -1.2 | -0.7 | 1.95 | 0.59 | Upgrade
|
| Total Common Equity | 1.85 | 24.17 | 44.57 | 84.5 | 81.54 | Upgrade
|
| Minority Interest | - | - | 22.36 | 23.46 | 22.03 | Upgrade
|
| Shareholders' Equity | 1.85 | 24.17 | 66.93 | 107.96 | 103.57 | Upgrade
|
| Total Liabilities & Equity | 53.67 | 75.27 | 96.23 | 138.3 | 127.73 | Upgrade
|
| Total Debt | - | 21.24 | 1.34 | 2.17 | 3.2 | Upgrade
|
| Net Cash (Debt) | 16.09 | 9.53 | 49.99 | 46.41 | 63.18 | Upgrade
|
| Net Cash Growth | 68.85% | -80.94% | 7.73% | -26.55% | 21.39% | Upgrade
|
| Net Cash Per Share | 1.05 | 0.71 | 3.66 | 3.41 | 5.72 | Upgrade
|
| Filing Date Shares Outstanding | 15.9 | 12.99 | 13.32 | 13.66 | 13.98 | Upgrade
|
| Total Common Shares Outstanding | 15.9 | 13.38 | 13.46 | 13.98 | 12.39 | Upgrade
|
| Working Capital | 3.12 | 42.62 | 56.42 | 48.78 | 66.05 | Upgrade
|
| Book Value Per Share | 0.12 | 1.81 | 3.31 | 6.04 | 6.58 | Upgrade
|
| Tangible Book Value | 1.61 | 22.33 | 43.51 | 72.3 | 68.33 | Upgrade
|
| Tangible Book Value Per Share | 0.10 | 1.67 | 3.23 | 5.17 | 5.51 | Upgrade
|
| Machinery | - | 6.68 | 1.24 | 1.73 | 1.62 | Upgrade
|
| Construction In Progress | - | 0.02 | 5.73 | 12.1 | 1.19 | Upgrade
|
| Leasehold Improvements | - | 7.19 | 7.16 | 1.13 | 0.99 | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.